Quantum Cyber N.V.
What this means
- Exchange listing at riskOn Mar 25, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Change of auditorOn Jun 26, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
- Change in controlOn Apr 28, 2026 the company reported a change in control (Item 5.01).
- Net loss in 2025Net loss of $16.2M for the year (2024: −$21.6M).
- Revenue downRevenue fell from $894K in 2024 to $537K in 2025 (40% lower).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $537K | $894K |
| Net income (loss) | −$16.2M | −$21.6M |
| Total assets | $5.3M | $13.5M |
| Total liabilities | $4.7M | $7.5M |
| Stockholders’ equity | $642K | $6M |
| Cash and equivalents | $889K | $6.2M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Quantum Cyber N.V.
Formerly: Mainz Biomed N.V. - CIK
- 0001874252
- Tickers
- QUCY
- Kind of filer
- SEC-reporting company
Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Netherlands
- Business address
- Mainz (outside the US)
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 13, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 5.02 · filed Oct 16, 2026 · filing
- Form 10-Q · filed Aug 14, 2026 · filing
- Form 8-K · items 2.01, 7.01, 8.01, 9.01 · filed Jul 16, 2026 · filing
- Form 8-K · items 5.02, 9.01 · filed Jul 7, 2026 · filing
- Form 8-K · items 4.01, 9.01 · filed Jun 26, 2026 · filing
- Form 8-K · items 1.01, 5.02, 9.01 · filed May 18, 2026 · filing
- Form 10-Q · filed May 15, 2026 · filing
- Form 8-K · items 1.01, 5.02, 9.01 · filed May 8, 2026 · filing
- Form 8-K · items 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01 · filed Apr 28, 2026 · filing
- Form 8-K · items 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01 · filed Apr 28, 2026 · filing
- Form SCHEDULE 13D · filed Apr 28, 2026 · filing
- Form 10-K · filed Mar 31, 2026 · filing
- Form 8-K · items 3.01 · filed Mar 25, 2026 · filing
- Form 8-K · items 5.02, 7.01, 8.01, 9.01 · filed Mar 11, 2026 · filing
- Form 8-K · items 1.01, 3.02, 3.03, 5.02, 8.01, 9.01 · filed Feb 17, 2026 · filing
- Form F-1 · filed Jul 30, 2025 · filing
- Form F-1 · filed May 14, 2025 · filing
- Form 20-F · filed Mar 31, 2025 · filing
- Form F-1 · filed Nov 5, 2024 · filing
- Form 20-F · filed Apr 9, 2024 · filing
- Form D · items 06b · filed Jul 11, 2023 · filing
- Form 20-F · filed Apr 7, 2023 · filing